|
advertisement
|
|
Top Stories
Through the agreement, Eli will expand its immunology pipeline with lebrikizumab, Dermira’s novel, investigational, monoclonal antibody designed to bind interleukin-13 with high affinity.
/ read more /
The new business unit, as well as a new leadership team formed by AbbVie, will be effective upon closing of the acquisition in the first quarter of 2020.
/ read more /
|
|
|
|
advertisement
|
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers
|
 |
|
|
|
advertisement
|
|
|
| |
PRODUCT SPOTLIGHT |
 |
Put our labware through its paces
Only the best laboratory glassware meets USP, EP and ASTM quality standards. That’s all DWK sells! Store your formulations with security in containment solutions by DWK Life Sciences. Ask your rep in for a special offer – discount prices and more!
/ click here to learn more / |
|
|
|
Industry News
The companies will kick off their partnership with CPhI North America, a conference that hosts the North American pharmaceutical supply chain.
/ read more /
The trial will test experimental stem-cell treatments against biologic therapies for severe forms of relapsing multiple sclerosis
/ read more /
More Industry News
|
|
|
|
advertisement
|
|
|
Supplier News
BioMed X and Merck have extended their ongoing collaboration with the commencement of a new joint research group, bringing the total joint projects being undertaken at the BioMed X Innovation Center to six.
/ read more /
Privately owned global pharmaceutical company, Galen, has announced the completion of its acquisition of a boutique healthcare company, POA Pharma.
/ read more /
More Supplier News
Bio/Pharma News
The therapy is currently approved in the EU as a gene therapy for the treatment of patients 12 years and older with transfusion-dependent β-thalassemia.
/ read more /
The approval comes after the results of a clinical trial that showed 61% of patients had a response lasting six months or longer.
/ read more /
More Bio/Pharma News
|
| | | | | | | | | | |
advertisement
|
| |
|
advertisement
|
|
Regulatory News
Can a commitment to limit prices to ensure patient access to important new medicines regain public trust and confidence in the biopharmaceutical industry?
/ read more /
The approval was based on successful data from a years-long trial that assessed patient’s tumor status every 12 or 24 weeks for up to 24 months.
/ read more /
More Regulatory News
|
|
Featured Topics |
|
ANALYTICS
Spectroscopic-based control methods were introduced as equivalent alternative methods, first to a gas chromatographic method to monitor an in-process solvent exchange step and second to a potentiometric titration method to release a process input material for drug substance manufacturing.
/ read more /
|
|
|
| |
|
FORMULATION
Particle morphology of magnesium stearate, added as an anti-caking agent in a high water soluble drug substance, has an influence on the dissolution rate of compressed tablets.
/ read more /
|
|
|
|
|
FILL-FINISH
Sterile filtration is often required for biologics but presents degradation and compatibility challenges.
/ read more /
|
|
|
Events
January 15–16, 2020
January 20–21, 2020
February 5–6, 2020
more events
|
|
|
eBOOKS
 |
In Pharmaceutical Technology's ongoing Pharmacopoeia Compliance Series, experts explain the revision process for global and national pharmacopoeias, best practices for monitoring changes, and how to participate in revisions. Other features include FDA warning letters, building a quality culture, and essentials for DOE and QRM.
|
|
|
|
|
|
Learn More
Learn More
Learn More